Literature DB >> 30718183

The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.

Jun Han1, Zhen-Li Li1, Hao Xing1, Han Wu1, Peng Zhu2, Wan Yee Lau3, Ya-Hao Zhou4, Wei-Min Gu5, Hong Wang6, Ting-Hao Chen7, Yong-Yi Zeng8, Meng-Chao Wu1, Feng Shen9, Tian Yang10.   

Abstract

BACKGROUND: The resection margin (RM) status and microscopic vascular invasion (MVI) are known prognostic factors for hepatocellular carcinoma (HCC). An enhanced understanding of their impact on long-term prognosis is required to improve oncological outcomes.
METHODS: Using multi-institutional data, the different impact of the RM status (narrow, <1 cm, or wide, ≥1 cm) and MVI (positive or negative) on overall survival (OS) and recurrence-free survival (RFS) after curative liver resection of solitary HCC without macrovascular invasion was analyzed.
RESULTS: In 801 patients, 306 (38%) had a narrow RM and 352 (44%) had positive MVI. The median OS and RFS were 109.8 and 74.8 months in patients with wide RM &amp; negative MVI, 93.5 and 53.1 months with wide RM &amp; positive MVI, 79.2 and 41.6 months with narrow RM &amp; negative MVI, and 69.2 and 37.5 months with narrow RM &amp; positive MVI (both P < 0.01). On multivariable analyses, narrow RM &amp; positive MVI had the highest hazard ratio with reduced OS and RFS (HR 2.96, 95% CI 2.11-4.17, and HR 3.15, 95% CI, 2.09-4.67, respectively).
CONCLUSIONS: Concomitant having narrow RM and positive MVI increases the risks of postoperative death and recurrence by about 2-fold in patients with solitary HCC.
Copyright © 2018 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30718183     DOI: 10.1016/j.hpb.2018.11.005

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  12 in total

Review 1.  Individualized Ablation of Hepatocellular Carcinoma: Tailored Approaches across the Phenotype Spectrum.

Authors:  Zlatko Devcic; Mohamed Elboraey; Lucas Vidal; Kabir Mody; Denise Harnois; Tushar Patel; Beau B Toskich
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

2.  Radiomic analysis based on multi-phase magnetic resonance imaging to predict preoperatively microvascular invasion in hepatocellular carcinoma.

Authors:  Yue-Ming Li; Yue-Min Zhu; Lan-Mei Gao; Ze-Wen Han; Xiao-Jie Chen; Chuan Yan; Rong-Ping Ye; Dai-Rong Cao
Journal:  World J Gastroenterol       Date:  2022-06-28       Impact factor: 5.374

3.  Individual and joint influence of cytokeratin 19 and microvascular invasion on the prognosis of patients with hepatocellular carcinoma after hepatectomy.

Authors:  Shang-Dong Qin; Jie Zhang; Ya-Peng Qi; Jian-Hong Zhong; Bang-De Xiang
Journal:  World J Surg Oncol       Date:  2022-06-21       Impact factor: 3.253

4.  Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study.

Authors:  Chetana Lim; Claire Goumard; Margarida Casellas-Robert; Santiago Lopez-Ben; Laura Lladó; Juli Busquets; Chady Salloum; Maria Teresa Albiol-Quer; Ernest Castro-Gutiérrez; Olivier Rosmorduc; Cyrille Feray; Emilio Ramos; Joan Figueras; Olivier Scatton; Daniel Azoulay
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

5.  Microscopic Portal Vein Invasion in Relation to Tumor Focality and Dimension in Patients with Hepatocellular Carcinoma.

Authors:  Brian I Carr; Vito Guerra; Rossella Donghia; Volkan Ince; Sami Akbulut; Veysel Ersan; Sertac Usta; Burak Isik; Emine Samdanci; Sezai Yilmaz
Journal:  J Gastrointest Surg       Date:  2021-09-10       Impact factor: 3.452

6.  Value of T1 mapping on gadoxetic acid-enhanced MRI for microvascular invasion of hepatocellular carcinoma: a retrospective study.

Authors:  Chenyi Rao; Xinquan Wang; Minda Li; Guofeng Zhou; Hongmei Gu
Journal:  BMC Med Imaging       Date:  2020-04-28       Impact factor: 1.930

7.  Prognostic Impact of Surgical Margin in Hepatectomy on Patients With Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies.

Authors:  Yeting Lin; Jiaxuan Xu; Jiaze Hong; Yuexiu Si; Yujing He; Jinhang Zhang
Journal:  Front Surg       Date:  2022-02-09

Review 8.  Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive Management.

Authors:  Zehao Zheng; Renguo Guan; Wang Jianxi; Zhen Zhao; Tianyi Peng; Chunsheng Liu; Ye Lin; Zhixiang Jian
Journal:  J Oncol       Date:  2022-03-30       Impact factor: 4.375

9.  Prognostic value of the ALBI grade among patients with single hepatocellular carcinoma without macrovascular invasion.

Authors:  Wenhao Chen; Zijian Zhang; Xianrui Fang; Li Xiong; Yu Wen; Jiangjiao Zhou; Fanhua Kong; Heng Zou
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

10.  Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma.

Authors:  Liang Xiao; Furong Zeng; Guangtong Deng
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.